+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ryzodeg 70/30 Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103999
The ryzodeg 70/30 market research report is one of a series of new reports that provides ryzodeg 70/30 market statistics, including the ryzodeg 70/30 industry global market size, regional shares, competitors with the ryzodeg 70/30 market share, detailed ryzodeg 70/30 market segments, market trends, and opportunities, and any further data you may need to thrive in the ryzodeg 70/30 industry. This ryzodeg 70/30 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to rising prevalence of diabetes, growing government initiatives to create awareness about diabetes, expanding diabetes screening programs, rising demand for injectable insulin therapies, and favorable regulatory approvals. Major trends in the forecast period include the integration of insulin analogs, integration with digital health tools, technological advancements in diabetes care devices, innovative tools to monitor glucose levels, and technological advancements in insulin delivery.

The growing prevalence of diabetes is expected to significantly contribute to the expansion of the ryzodeg 70/30 market in the coming years. Diabetes is a chronic condition where the body either doesn't produce enough insulin or can't use it effectively, resulting in high blood sugar levels. The rise in diabetes cases can be attributed to factors such as poor diets, sedentary lifestyles, obesity, genetic factors, an aging population, and more widespread awareness and diagnosis. Ryzodeg 70/30, a combination insulin product, aids in diabetes management by providing both basal and bolus insulin action. This dual action helps regulate blood sugar levels throughout the day and night, which is essential for individuals with type 1 and type 2 diabetes to maintain stable glucose levels and improve overall glycemic control. For example, between March 2022 and March 2023, the Office for Health Improvement and Disparities in the UK reported a 22% increase in the number of individuals with type 1 diabetes receiving all recommended care processes, and a 21% increase for type 2 diabetes, with 37.9% of individuals reaching target HbA1c levels. Thus, the increasing prevalence of diabetes is fueling the growth of the ryzodeg 70/30 market.

The factor driving market growth is the rising aging population, which poses a challenge to healthcare systems and demands greater attention to chronic conditions such as diabetes. This demographic shift, characterized by a growing proportion of elderly individuals, is influenced by longer life expectancy, lower birth rates, and advancements in healthcare. Ryzodeg 70/30 supports the aging population by offering a simplified, flexible, and stable blood sugar control solution with a reduced risk of hypoglycemia, thereby improving diabetes management and quality of life. According to the Population Reference Bureau, the number of Americans aged 65 and older is projected to increase by 47%, from 58 million in 2022 to 82 million by 2050, which will make up 23% of the total population. This trend highlights the growing need for effective diabetes treatments, driving demand for products such as ryzodeg 70/30.

The rising healthcare investments are expected to propel the growth of the ryzodeg 70/30 market. These investments, which fund medical technologies, pharmaceuticals, healthcare services, and facilities, are increasing as the aging population requires more healthcare services and as innovations in medical technology continue to improve patient care. Healthcare investments play a critical role in supporting the development and distribution of ryzodeg 70/30, funding clinical trials, production expansion, and securing regulatory approvals to ensure broader accessibility and adoption. For instance, healthcare spending in the US rose by 4.1% in 2022, reaching $4.5 trillion, according to the National Institutes of Health, marking an acceleration from the previous year's growth rate. Therefore, the rising healthcare investments are further contributing to the expansion of the ryzodeg 70/30 market.

The key company operating in the ryzodeg 70/30 market is Novo Nordisk A/S

North America was the largest region in the ryzodeg 70/30 market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ryzodeg 70/30 report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ryzodeg 70/30 market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Ryzodeg 70/30 is a combination insulin made up of 70% insulin degludec (long-acting) and 30% insulin aspart (rapid-acting). It is used to manage blood sugar levels in individuals with type 1 or type 2 diabetes, providing both immediate and long-lasting effects.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for Ryzodeg 70/30 are type 1 diabetes and type 2 diabetes. Type 1 diabetes is an autoimmune condition in which the body attacks and destroys insulin-producing cells in the pancreas, necessitating lifelong insulin therapy for blood sugar management. Ryzodeg 70/30 is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies. It is used in diverse settings such as hospitals, clinics, home care environments, and long-term care facilities.

The ryzodeg 70/30 market consists of sales of products including the flextouch pen, novopen 5, vial, cartridge, and kwikpen. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Ryzodeg 70/30 Market Characteristics
3. Ryzodeg 70/30 Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Ryzodeg 70/30 Market Trends And Strategies5. Ryzodeg 70/30 Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Ryzodeg 70/30 Growth Analysis And Strategic Analysis Framework
6.1. Global Ryzodeg 70/30 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Ryzodeg 70/30 Market Growth Rate Analysis
6.4. Global Ryzodeg 70/30 Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Ryzodeg 70/30 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Ryzodeg 70/30 Total Addressable Market (TAM)
7. Global Ryzodeg 70/30 Pricing Analysis & Forecasts
8. Ryzodeg 70/30 Market Segmentation
8.1. Global Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Type 1 Diabetes
  • Type 2 Diabetes
8.2. Global Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
8.3. Global Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospitals And Clinics
  • Home Care Settings
  • Long-Term Care Facilities
9. Global Ryzodeg 70/30 Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Ryzodeg 70/30 Market Regional And Country Analysis
10.1. Global Ryzodeg 70/30 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Ryzodeg 70/30 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Ryzodeg 70/30 Market
11.1. Asia-Pacific Ryzodeg 70/30 Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Ryzodeg 70/30 Market
12.1. China Ryzodeg 70/30 Market Overview
12.2. China Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Ryzodeg 70/30 Market
13.1. India Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Ryzodeg 70/30 Market
14.1. Japan Ryzodeg 70/30 Market Overview
14.2. Japan Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Ryzodeg 70/30 Market
15.1. Australia Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Ryzodeg 70/30 Market
16.1. South Korea Ryzodeg 70/30 Market Overview
16.2. South Korea Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Ryzodeg 70/30 Market
17.1. Western Europe Ryzodeg 70/30 Market Overview
17.2. Western Europe Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Ryzodeg 70/30 Market
18.1. UK Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Ryzodeg 70/30 Market
19.1. Germany Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Ryzodeg 70/30 Market
20.1. France Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Ryzodeg 70/30 Market
21.1. Eastern Europe Ryzodeg 70/30 Market Overview
21.2. Eastern Europe Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Ryzodeg 70/30 Market
22.1. North America Ryzodeg 70/30 Market Overview
22.2. North America Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Ryzodeg 70/30 Market
23.1. USA Ryzodeg 70/30 Market Overview
23.2. USA Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Ryzodeg 70/30 Market
24.1. Canada Ryzodeg 70/30 Market Overview
24.2. Canada Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Ryzodeg 70/30 Market
25.1. South America Ryzodeg 70/30 Market Overview
25.2. South America Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Ryzodeg 70/30 Market
26.1. Middle East Ryzodeg 70/30 Market Overview
26.2. Middle East Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Ryzodeg 70/30 Market
27.1. Africa Ryzodeg 70/30 Market Overview
27.2. Africa Ryzodeg 70/30 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Ryzodeg 70/30 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Ryzodeg 70/30 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Ryzodeg 70/30 Market Competitive Landscape And Company Profiles
28.1. Ryzodeg 70/30 Market Competitive Landscape
28.2. Ryzodeg 70/30 Market Company Profiles
28.2.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
29. Global Ryzodeg 70/30 Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Ryzodeg 70/30 Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Ryzodeg 70/30 Market32. Recent Developments In The Ryzodeg 70/30 Market
33. Ryzodeg 70/30 Market High Potential Countries, Segments and Strategies
33.1 Ryzodeg 70/30 Market In 2029 - Countries Offering Most New Opportunities
33.2 Ryzodeg 70/30 Market In 2029 - Segments Offering Most New Opportunities
33.3 Ryzodeg 70/30 Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Ryzodeg 70/30 Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ryzodeg 70/30 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for ryzodeg 70/30 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ryzodeg 70/30 market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Indication: Type 1 Diabetes; Type 2 Diabetes
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Hospitals And Clinics; Home Care Settings; Long-Term Care Facilities

Key Companies Profiled: Novo Nordisk A/S

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Novo Nordisk A/S